FundedIQ

Recently Funded Biotechnology & Pharmaceuticals Startups

Updated Sep 2026

FundedIQ tracks 29 funded Biotechnology & Pharmaceuticals startups, with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology & Pharmaceuticals startup funding landscape, along with the 29 most recently funded Biotechnology & Pharmaceuticals startups.

Hangzhou and Cambridge hold the deepest concentrations of these companies. Biotechnology & Pharmaceuticals startups closed 31 funding rounds over the last 24 months, 31 of them in the last 12 months, and raised $1.1B in disclosed capital. The median disclosed round is $21M, with the middle half of rounds falling between $14M and $56M.

Biotechnology funding concentrates heavily in Hangzhou and Cambridge. This geographic density creates a distinct center of gravity for the sector. While the United States and China lead the global spread, a few specific cities dominate the activity. Targeting this segment involves focusing on these primary clusters rather than a broad international search.

Biotechnology & Pharmaceuticals funded startup statistics

Funded Biotechnology & Pharmaceuticals startups
29
tracked in the database
Funding rounds, last 12 months
31
31 over 24 months
Disclosed capital raised, 24 months
$1.1B
21 of 31 rounds disclosed an amount
Median round size
$21M
middle half $14M to $56M

Most recent funding round on record: Aug 2026.

29 most recently funded Biotechnology & Pharmaceuticals startups

29 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

A
Foster City, United States · Biotechnology, Pharmaceuticals
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Series C ·
$120M
O
Austin, United States · Biotechnology, Pharmaceuticals
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Series B ·
$330M
D
Cambridge, United States · Biotechnology, Pharmaceuticals
Dayra Therapeutics manufactures peptide based medicines.
Venture - Series Unknown ·
$20M
H
Healsun Biopharm
Hangzhou, China · Biotechnology, Pharmaceuticals
Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO
Series C ·
Undisclosed
M
Miramoon Pharma
San Sebastian, Spain · Biotechnology, Pharmaceuticals
Miramoon Pharma is a biotechnology company based in San Sebastián, that develops first-in-class…
Seed ·
Undisclosed
4
Hennigsdorf, Germany · Biotechnology, Pharmaceuticals
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Series C ·
$36M
K
Hangzhou, China · Biotechnology, Pharmaceuticals
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Series C ·
$56M
S
Kagoshima, Japan · Biotechnology, Pharmaceuticals
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary…
Series B ·
$9.8M
B
Shanghai, China · Biotechnology, Pharmaceuticals
Brise Pharma operates in the scientific research and technical service industry.
Series A ·
$28M
V
Hangzhou, China · Biotechnology, Pharmaceuticals
Vybio is a high-tech enterprise focusing on innovative drug research and development.
Series B ·
$14M
N
Norn Gene
Chengdu, China · Biotechnology, Pharmaceuticals
Norn Gene is a nucleic acid drug delivery with its advanced LNP⊕ platform.
Series A ·
Undisclosed
C
Changsen Pharmaceutical
Shanghai, China · Biotechnology, Pharmaceuticals
Changsen Pharmaceutical is a high-tech enterprise specializing in the research and development of oncology…
Series B ·
Undisclosed
C
Farmingdale, United States · Biotechnology, Pharmaceuticals
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Pre-Seed ·
$3.1M
B
San Francisco, United States · Biotechnology, Pharmaceuticals
Bexorg provides a technology platform for central nervous system drug discovery and development.
Series A ·
$23M
A
Marseille, France · Biotechnology, Pharmaceuticals
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates…
Series A ·
$122M
A
La Jolla, United States · Biotechnology, Pharmaceuticals
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Series A ·
$21M
O
Rockville, United States · Biotechnology, Pharmaceuticals
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Series B ·
$50M
A
Appfinder Therapeutics
Anyang, South Korea · Biotechnology, Pharmaceuticals
AppFinder develops PepFc® peptide and AbFinder® antibody platforms for innovative drug discovery and…
Seed ·
Undisclosed
O
Scottsdale, United States · Biotechnology, Pharmaceuticals
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
Venture - Series Unknown ·
$14M
A
Cambridge, United States · Biotechnology, Pharmaceuticals
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
Series A ·
$5.0M
T
Marseille, France · Biotechnology, Pharmaceuticals
Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.
Series A ·
$14M
M
Mondego Bio
Cantanhede, Portugal · Biotechnology, Pharmaceuticals
Mondego Bio is a new Portuguese startup developing breakthrough cancer treatments.
Series A ·
Undisclosed
V
VS PharmTech
Daegu, South Korea · Biotechnology, Pharmaceuticals
VS PharmTech is a clinical-stage biotechnology company for cancer therapies.
Series B ·
Undisclosed
H
Suzhou, China · Biotechnology, Pharmaceuticals
HiDiamond Biotechnology is a biopharmaceutical company offering research and development for therapeutic…
Seed ·
$14M
S
San Diego, United States · Biotechnology, Pharmaceuticals
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Series C ·
$5.4M
C
Cantoni Therapeutics
Oss, The Netherlands · Biotechnology, Pharmaceuticals
Cantoni Therapeutics is committed to finding and creating the greatest small molecule inhibitors available.
Seed ·
Undisclosed
E
La Jolla, United States · Biotechnology, Pharmaceuticals
Enlaza Therapeutics is a biotechnology research company.
Venture - Series Unknown ·
$15M
R
RabPharma
Guangdong, China · Biotechnology, Pharmaceuticals
RabPharma specializes on the discovery and development of new drugs for bone and joint diseases.
Series A ·
Undisclosed
A
Affinity
Pudong, China · Biotechnology, Pharmaceuticals
Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global…
Series B ·
Undisclosed

Countries with the most funded Biotechnology & Pharmaceuticals startups

Where funded Biotechnology & Pharmaceuticals startups are headquartered, by the country on the company record.

Where are funded Biotechnology & Pharmaceuticals startups located?

Where funded Biotechnology & Pharmaceuticals startups are based, by the city on the company record.

City
Funded startups

Funding stages of funded Biotechnology & Pharmaceuticals startups

How the last 24 months of funding rounds for funded Biotechnology & Pharmaceuticals startups break down by stage.

Stage
Rounds, last 24 months

A further 3 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology & Pharmaceuticals startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 29 funded Biotechnology & Pharmaceuticals startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (10 of 31 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology & Pharmaceuticals startups is dated Aug 2026.

The table above shows the 29 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology & Pharmaceuticals startups are there?

FundedIQ tracks 29 funded Biotechnology & Pharmaceuticals startups. This page lists the 29 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology & Pharmaceuticals startups raised?

Biotechnology & Pharmaceuticals startups tracked by FundedIQ have raised $1.1B in disclosed capital across 31 funding rounds over the last 24 months, including 31 rounds in the last 12 months. 21 of those 31 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Biotechnology & Pharmaceuticals startups?

United States leads with 11 companies, ahead of China (9), France (2) and South Korea (2).

Which cities have the most funded Biotechnology & Pharmaceuticals startups?

Hangzhou leads with 3 companies, then Cambridge (2), La Jolla (2) and Marseille (2).

What is a typical funding round size for Biotechnology & Pharmaceuticals startups?

The median disclosed round over the last 24 months is $21M, and the middle half of rounds fall between $14M and $56M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology & Pharmaceuticals startups?

Series A is the most common labelled stage, with 10 rounds in the last 24 months, ahead of Series B (8) and Series C (5). A further 3 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology & Pharmaceuticals startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology & Pharmaceuticals startups is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.